4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001193125-26-129239
Director sold 14,295 shares at $36.97 ($528,506)
- Director returned 53,172 shares (to the company)
- Director acquired 53,172 shares (option exercise)
- Director acquired 14,295 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAPLAN GILLA Director | 2026-03-25 | Option exercise | +14,295 | $2.25 | $32,164 | 42,526 | D: show line 1 in the form |
| KAPLAN GILLA Director | 2026-03-25 | Sale | −14,295 | $36.97 | $528,506 | 28,231 | D: show line 2 in the form |
| KAPLAN GILLA Director | 2026-03-26 | Option exercise | −53,172 | $2.25 | $119,637 | 81,403 | D: show line 3 in the form |
| KAPLAN GILLA Director | 2026-03-26 | Returned to the company | −53,172 | $37.75 | $2,007,153 | 28,231 | D: show line 4 in the form |
| Open-market sales · 14,295 sh · avg $36.97 · $528,506 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KAPLAN GILLA Director | 2026-03-25 | Option exercise · Stock Option (Right to Buy) | −14,295 | 53,172 | D: show line 5 in the form | |||||
| KAPLAN GILLA Director | 2026-03-26 | Option exercise · Stock Option (Right to Buy) | −53,172 | 0 | D: show line 6 in the form |
Loading xslF345X06/ownership.xml…